Hervé Bourhy

Hervé Bourhy is a professor and head of the Global Health Department, the Lyssavirus, Epidemiology and Neuropathology Laboratory, the WHO Collaborating Center for Rabies Reference and Research and the National Reference Center for Rabies at the Institut Pasteur in Paris, France.
His research activities mainly aim to generate a paradigm shift in the way rabies is monitored, studied and controlled, bringing it into the era of One Health and Precision Public Health. His work focuses on questions relating to disease persistence and dispersion, reservoir dynamics (dogs, bats), crossing of the species barrier and modalities and physiopathological consequences of the neurotropism of viruses such as rabies virus and SARS-CoV-2 and development of new antiviral strategies against the rabies virus and SARS-CoV-2. He has published more than 195 papers in peer reviewed international journals.

Roland Brosch

Roland Brosch obtained his PhD at the University of Salzburg, Austria and after his postdoctoral work at the University of Wisconsin and the Institut Pasteur in Paris, he integrated into the scientific staff of the Institut Pasteur. 

He worked on groundbreaking genome projects of the tuberculosis agent Mycobacterium tuberculosis, the BCG vaccine, and M. canettii as well as on the evolution of the M. tuberculosis complex, and the discovery and characterization of the ESX / type VII mycobacterial secretion systems. 

He is now a Professor and Head of a research unit and continues to be very interested in the above mentioned topics in order to gain new insights into mycobacterial evolution and host-pathogen interaction, crucial for new vaccine and treatment concepts.

Arturo Casadevall

Arturo Casadevall, MD, PhD, is a Bloomberg Distinguished Professor and Alfred and Jill Summer Chair of the Molecular Microbiology and Immunology at Johns Hopkins School of Public Health. He received his MD and PhD degrees from New York University. He completed his internship/residency in internal medicine at Bellevue Hospital and specialized in Infectious Diseases at the Albert Einstein College of Medicine. The author of over 900 papers, books and chapters, his major research interests are in fungal pathogenesis and the mechanisms of antibody action. He is editor-in-chief of mBio, Deputy Editor of the Journal of Clinical Investigation and serves on several editorial boards. He has served on the National Science Board for Biosecurity and the National Commission on Forensic Science.

He is currently chair of the Board of Governors of the American Academy of Microbiology, the honorific arm of the American Society for Microbiology. He has received numerous honors including election to the American Society for Clinical Investigation, American Academy of Physicians, American Academy of Microbiology, Fellow of the American Academy for the Advancement of Science, American Academy of Arts and Sciences, the National Academy of Medicine and the National Academy of Science.

Stewart Cole

Stewart Cole is an internationally renowned scientist and Professor of Microbial Pathogenesis. Since January 2nd, 2018, he is President of the Institut Pasteur. From 2007 to 2017, he has served as Professor and Director of the Global Health Institute at the Ecole polytechnique fédérale de Lausanne, the Swiss Federal Institute of Technology (EPFL) – a world-leading education and research center.

For 24 years Cole worked as a researcher and also held various research management positions at the Institut Pasteur. He was Director of Strategic Technologies and then Executive Scientific Director, contributing to several patent applications relating to HIV/AIDS, cervical cancer and multidrug-resistant tuberculosis. He participated in the Scientific Advisory Boards of the Institut Pasteur in Iran, the Institut Pasteur in Montevideo and the Institut Pasteur in Lille. Professor Cole was also acting President of the Institut Pasteur in Paris in 2005.

He has been the recipient of many national and international prizes and distinctions. In 2009, he was awarded the World Health Organization’s prestigious Stop-TB Partnership Kochon Prize for his leadership and groundbreaking accomplishments in genetic research on M. tuberculosis and his contribution to novel therapeutic strategies for tackling TB. During his career, he has been involved in the work of several foundations and scientific committees, and was notably Chair of the board of the Innovative Medicine for Tuberculosis Foundation and President of the commission médicale for the Fondation Raoul Follereau. Stewart Cole has also published more than 350 scientific papers on infectious diseases, most notably tuberculosis and leprosy. Professor Cole was awarded with the title of Chevalier of the Legion of Honor in 2004 and was appointed as Knight Commander of the Order of St. Michael and St. George for service to science, on January 1st, 2022.

Pascale Cossart

Pascale Cossart, after studying chemistry in Lille (France), obtained a master degree at Georgetown University, Washington, DC.

Back in France, she obtained her PhD in Paris in the Institut Pasteur where she has headed the ‘Bacteria-Cell Interactions’ unit until recently. After studying DNA-protein interactions in E. coli, in 1987 she started to study the molecular and cellular basis of infections by intracellular bacteria, taking as a model the bacterial pathogen Listeria monocytogenes.

She pioneered the field of Cellular Microbiology. Her research led to new concepts in infection biology, but also in fundamental microbiology – in particular RNA regulation, in cell biology and also in epigenetics. Her contributions have been recognized by many awards, including the Robert Koch Prize (2007), the Louis Jeantet Prize for Medicine (2008), the Balzan Prize (2013), the Heinrich Wieland prize (2018), and the NAS Selman Waksman Award (2021).

She is a member of the French Academy of Sciences (2002), the American National Academy of Science (NAS) (2009), the German Leopoldina (2001), the Royal Society (2010) and the National Academy of Medecine (NAM) (2014).

From 2016 to 2021, she was the Permanent Secretary of the French Academy of Sciences. She is now a scientific visitor at EMBL Heidelberg.

David Couvin

Dr. David Couvin is a bioinformatics researcher, working at the Institut Pasteur de la Guadeloupe on various bioinformatics projects, including Mycobacterium tuberculosis

His PhD thesis (which he defended in December 2014, under the supervision of Dr. Nalin Rastogi) focused on the development and refinement of a global database of circulating genotypes of Mycobacterium tuberculosis strains (SITVIT2). 

After his PhD thesis, he worked on comparative genomics projects at CIRAD Montpellier (France), then carried out another contract at the Institute of Integrative Biology of the Cell (CNRS, Université Paris-Saclay) which consisted in developing a prediction tool and database of CRISPR-Cas systems from bacteria and archaea genomes.

Patrizia Danesi

Patrizia Danesi is a senior researcher at the Laboratory of Parasitology, Mycology and Medical Enthomology laboratory at the IZSVe (Istituto Zooprofilattico Sperimentale delle Venezie, Padua, Italy). She graduated in Veterinary Medicine (University of Bologna) and defended her PhD thesis (2014 University of Bari) on epidemiology and genetic characterisation of Cryptococcus species in feral cats. She obtained the Medical Mycology diploma in the Pasteur Institute (Paris) in 2007.

Her research includes the development of rapid and reliable methods for the diagnosis of fungal and parasitological infection mainly focus on dermatophytes, Cryptococcus, Pneumocystis and Prototheca, Giardia and Leishmania in companion and wild animals. Together with Professors Malik and Krockenberger (University of Sydney) she is interested in studying the role of animals as sentinels for human exposure to environmental fungal pathogens.

Jean-Marc Ghigo

Jean-Marc Ghigo runs the Genetics of Biofilms Laboratory in the Department of Microbiology at Institut Pasteur, Paris. For the past 30 years, he investigated the molecular bases of various bacterial processes, and since 2001, he’s been studying new aspects of surface-attached bacterial communities called biofilms. 

His research addresses 3 main inquiries: How do bacteria form biofilms? What properties emerge from bacterial communities? How can we limit biofilm formation? 

His laboratory uses bacterial genetics approaches, as well as in vitro and in vivo models to: i) identify adhesion factors; ii) investigate biofilm-specific properties; iii) study biofilm tolerance to biocides and design anti-biofilm strategies; iv) study bacterial competition within mixed-species communities. 

For more information see here.

Marek Gniadkowski

Marek Gniadkowski received his MSc in 1987 at the Department of Genetics, University of Warsaw, where he then worked until 1995.

In 1992 he defended his doctoral dissertation under the supervision of Prof. E. Bartnik. In 1994 he completed a 2.5-year postdoctoral fellowship in the Friedrich-Miescher Institute in Basel, in the laboratory of Prof. W. Filipowicz. In 1995 he started his work in the Central Laboratory of Sera and Vaccines, in the group of Prof. W. Hryniewicz, from 2002 being part of the National Medicines Institute.

Since 1997 he has been a Head of the Department of Molecular Microbiology, dealing with the issues of molecular epidemiology of bacterial infections. His research team focuses mostly on multidrug-resistant Gram-negative bacteria, clonal structure of their populations, and the mechanisms of β-lactam resistance.

In 2004 he defended his habilitation, and in 2011 obtained the title of Professor of medical sciences at the Warsaw Medical University.

Andrzej Górski

Andrzej Górski is a Professor of medicine and immunology at the Medical University of Warsaw. He specializes in internal diseases, immunology, and transplantology. 

Since 1999 he heads the Phage Therapy Unit of the Medical Centre of the L. Hirszfeld Institute of Immunology and Experimental Therapy at the Polish Academy of Sciences. He’s been a Director of this Institute from 1999 to 2007, Vice-Rector (1993-1996), Rector of the Medical University of Warsaw (1996-1999) and Vice-President of the Polish Academy of Sciences (2007-2015), as well as a Member of the European Group on Ethics in Science and New Technologies (2011-2015). 

Prof. Górski had several research appointments at various prestigious foreign institutions (e.g. Sloan-Kettering Institute for Cancer Research, USA; Fred Hutchinson Cancer Research Center, USA; Karolinska Institutet, Sweden; Weizmann Institute of Science, Israel) and received many scientific awards, including the Meller Award for excellence in cancer research from the Sloan-Kettering Institute, the ICRETT Award and the Yamagiwa-Yoshida Award from the International Union Against Cancer, the Jędrzej Śniadecki Memorial Award from the Polish Academy of Sciences.

Prof. Górski has authored more than 430 scientific publications (H-index 45). He serves as the editor-in-chief of Archivum Immunologiae et Therapiae Experimentalis, and as an editor of Science & Engineering Ethics.

Sybren de Hoog

Sybren de Hoog is a senior researcher at the Center of Expertise in Mycology of Radboud University Medical Center and Canisius Wilhelmina Hospital in Nijmegen, The Netherlands. 

He was a professor of mycology at the Institute of Biodiversity and Ecosystem Dynamics of the University of Amsterdam, and holds visiting professorships at universities of Beijing, Guiyang, Nanjing and Suzhou in China, and Curitiba in Brazil.  He is the past-President of the International Society for Human and Animal Mycology (ISHAM). In this function he assisted in the organization of ISHAM and satellite congress in Tokyo and Beijing in 2009. He was the program chairman of the TIFI/ECMM congress in Amsterdam (2003) and of the ISHAM Congress in Amsterdam (2018). 

He is the first author of the Atlas of Clinical Fungi which appeared in print in 2020 (1599 pages, >4000 citations) and for which there is a continually updated electronic version with molecular data available. 

His teaching activities comprise the International Course Medical Mycology for hospital personnel, with editions in Europe, China, USA and Brazil. Currently he (co-)guides 7 international PhD students and postdocs. 

His research focuses on evolution of medically relevant fungi in dermatophytes and black yeasts. He has written more than 900 scientific publications (H-index 107).

Łukasz Kozubowski

Dr. Łukasz Kozubowski received his MS degree in pharmaceutical sciences at the Medical University of Warsaw under the mentorship of Dr. Jozef Sawicki and Dr. Grzegorz Nałęcz-Jawecki; and a doctorate in Biochemistry and Molecular Biology at the Louisiana State University Medical Center under the mentorship of Dr. Kelly Tatchell.

He then conducted postdoctoral studies on establishment of cell polarity based on S. cerevisiae model in the laboratory of Dr. Daniel Lew at the Duke University, followed by studies on pathogenesis of Cryptococcus neoformans in laboratories of Dr. Joseph Heitman, Dr. Andy Alspaugh, and Dr. John Perfect.

He is an Associate Professor at Clemson University where his research group investigates the impact of stress response on fungal pathogenesis and susceptibility to antifungal drugs.

Marc Lecuit

Marc Lecuit is a microbiologist and an infectious diseases physician. He is the director of the Biology of Infection Unit at Institut Pasteur and Inserm, and the chair of the Department of Cell Biology and Infection at Institut Pasteur.

Marc is a professor at Université Paris Cité and senior attending physician, deputy head of the Department of Infectious Diseases and Tropical Medicine at the Necker-Enfants Malades University Hospital. His research focuses on understanding the molecular mechanisms underlying the ability of microbes to target specific hosts, infect host cells, cross host barriers and disseminate systemically and within tissues, as well as on how host responses affect infection outcome. His laboratory focuses on pathogens that have the ability to induce maternal-fetal and central nervous system infections.

Marc Lecuit has made important contributions to the understanding of the biology of infections caused by Listeria monocytogenes, as well as emerging pathogens such chikungunya, Zika and SARS-CoV-2 viruses. He is also involved in translational research projects in the Institut Pasteur international network.

Marc is supported by the European Research Council. He is an appointed Fellow of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), a member of the European Molecular Biology Organization (EMBO) and Academia Europaea and senior member of Institut Universitaire de France.

Jean-Claude Manuguerra

Jean-Claude Manuguerra (JCM) was originally qualified as a veterinarian at the Ecole Nationale Vétérinaire d’Alfort close to Paris, and was trained in virology at Institut Pasteur in order to get his PhD at the University Paris XI. He spent two years as a post-doctoral fellow at the National Institute for Medical Research (London, United Kingdom). He was then a co-director of the National Influenza Centre for Northern France, one of the 13 laboratories included in the WHO Collaborative Multi-Centre Laboratory Network on SARS (1994-2003). He belonged to the French team sent to Hanoi for the control of the SARS outbreak in March 2003. Since then, he participated in a number of missions during outbreaks (Seasonal influenza, Madagascar 2002; SARS Hanoi 2003; H5N1 avian influenza, Phom Pehn 2004; Pandemic influenza H1N1, Mexico 2009; MERS, Riyad 2013; Ebola, Conakry 2014 & Macenta 2015).
From 2000 to 2018, JCM was a member of the steering committee of the Global Alert and Response Network (GOARN) and chaired it from 2011 to 2013. From 1998 to 2001, he was the Secretary General of the French Society for Microbiology. He was a member of the Scientific Council of the National Veterinary School of Alfort (2005-2014). From 2003 to 2010, JCM was the Chair of the National French Committee for influenza pandemic planning.

Currently, JCM – Research Director at Institut Pasteur, heads the Environment and Infectious Risks expertise and research Unit which harbors the Laboratory for Emergency Response to Biological Threats and the National Reference Centre for Hantaviruses. He is the Chief Editor of Intervirology since 2012.
JCM is currently the Vice-Chairperson of SAGO (WHO Scientific Advisory Group on the Origin of emerging and re-emerging pathogens with pandemic and epidemic potential).

Since 2005, he is a corresponding member of the Académie Vétérinaire de France which Louis Pasteur was a member of. JCM holds the titles of Chevalier de l’Ordre National du Mérite (Knight of the National Order of Merit) and Chevalier de la Légion d’Honneur (Knight of the Legion of Honour) – which are prestigious French honors.

Robin May

Robin May is a Professor of Infectious Diseases within the Institute of Microbiology & Infection at the University of Birmingham, UK. He is currently on a 60% secondment to the UK Government, serving as Chief Scientific Adviser to the Food Standards Agency.

His early training was in Plant Sciences (University of Oxford) followed by a PhD on mammalian cell biology with Prof. Laura Machesky (University College London & University of Birmingham). From 2001-2004 he was a Human Frontier Science Program fellow with Prof. Ronald Plasterk at the University of Utrecht, The Netherlands, working on RNA interference mechanisms. In 2005 he obtained a Research Council UK Fellowship to establish his own group at the University of Birmingham. In 2010 he was awarded a Lister Fellowship, in 2013 he was presented with the Colworth Medal of the Biochemical Society and in 2015 he received Wolfson Research Merit Award from the Royal Society. From 2014-2020 Prof. May held a Consolidator Award from the European Research Council and in 2020 was elected to Fellowship of the American Academy of Microbiology.

Prof. May’s research interests focus on host-pathogen interactions and, in particular in understanding how some pathogens are able to subvert the innate immune system. Much of his work is aimed at improving the treatment or prevention of opportunistic infections in patients with impaired immunity, such as HIV-positive individuals, patients in critical care, or people with long-term immune-compromising conditions.

Didier Mazel

Didier Mazel defended in 1990 his PhD in Molecular and Cellular Genetics on the characterization of the genes encoding the light harvesting complexes in cyanobacteria. In parallel, he demonstrated that metabolic constraints linked to elemental sulfur availability in the different types of water colonized by cyanobacteria, were imprinted in their protein sequences.
From that, he has made several important contributions to the study of antibiotics and antibiotic resistance, including understanding of the mechanisms of the integron capture and dissemination of resistance genes.

Didier Mazel and his collaborators study genome organization and chromosome maintenance mechanisms in Vibrio cholerae, which is constituted of 2 circular chromosomes (chr). They identified the unique mechanism that coordinates chr2 replication, to ensure synchronous replication termination for the two chromosomes.

Recently, he became one of the pioneers who leverage synthetic biology to invent novel antimicrobials by developing an original system that kills specifically V. cholerae in complex populations.

Jan Potempa

Jan Potempa defended his PhD (1982) and DSc (habilitation, 1993) in Biochemistry at the Jagiellonian University, Krakow, Poland. He holds a Doctorate Honoris Causa from the University of Lund and University of Amsterdam.

Currently, Dr. Potempa is affiliated with the University of Louisville Dental School, where he is a Full Professor and Distinguished Academic Scholar. He also maintains a teaching and research position at the Jagiellonian University, where he is a Research Professor (since 2005) and head of the Department of Microbiology (since 2001).
He received the most prestigious awards for scientific achievements in Poland: FNP Prize (2011) and the Heisig Award (2021).

His current investigations are focused on virulence factors of bacterial pathogens that play important roles in the dysregulation of several physiological pathways and evasion of host immunity, especially in the context of periodontitis and associated diseases.

Daniel Raichvarg

Daniel Raichvarg obtained his PhD at the University of Paris 7, France, in the fields of communication, pedagogy, and history of sciences. He held a position of senior lecturer at the University of Paris-Orsay in these fields. He then became full professor of communication sciences at the University of Burgundy where he created a research unit in communication sciences (Lab. CIMEOS) and developed the Science and Society programme at his University. He is now professor emeritus of communication sciences at the University of Burgundy. He is a Honorary President of the French Society for Information and Communication Studies, after a two-term Presidency.

He is an international expert in the fields of science and society-related issues and cultural outreaches. He is helping to develop projects of Terre de Louis Pasteur – sciences and heritage, public cultural cooperation establishment under the responsibility of the French Academy of Sciences.

Juan Luis Ramos

Juan L. Ramos is a Full Professor at CSIC-EEZ in Granada. His multidisciplinary research approach comes from the “bench to field” process, integrating molecular biology, chemical engineering and field assays. He has greatly deepened the knowledge of microbial physiology, genetics and molecular ecology and applied it in order to come up with better ways of restoring polluted sites using microbial biodegradation. 

Juan Luis has supervised 47 PhD theses and the work of 50 post-docs from 5 continents. 

He is an elected member of the American Academy of Microbiology, the European Academy of Microbiology and Académico Numerario (medal 13) of the Granada Academy of Sciences.

In 2012 he received the prestigious Jaime I Award for Environmental Protection, and in 2013 – the Lwoff medal of FEMS in recognition for his contribution.

Uwe H. Rösler

Uwe Harry Rösler was born in 1971, is married and has two almost grown-up sons.
He studied veterinary medicine in Leipzig, Germany, until 1997. He received his doctorate degree in 2001 and his habilitation in 2007, both at the Institute for Animal Hygiene and Veterinary Public Health at the University of Leipzig. He received appointments to senior professorships (W3) in animal and environmental hygiene in i.a. Stuttgart (Hohenheim), Hanover and Berlin.

He has been a Senior Professor for Animal Hygiene and Infectiology at the Department of Veterinary Medicine at the Free University of Berlin since 2008, where he holds the position of Head of the Institute for Animal Hygiene and Environmental Health. He is currently the Dean of the Department of Veterinary Medicine at the Free University of Berlin and is also involved in numerous national and international committees focused on infection prevention and disinfection.

His research interests focus on the epidemiology and control of infectious diseases (including Salmonella, Campylobacter and Prototheca infections) and antimicrobial resistance.

Ilan Schwartz

Ilan Schwartz is an infectious diseases physician and researcher in the Division of Infectious Diseases at Duke University.

His clinical and research interests involve emerging fungal infections, immunocompromised hosts, and global health. After his clinical training in Canada, he obtained a Doctorate in Medical Sciences from the University of Antwerp for research on emergomycosis, a novel opportunistic fungal infection affecting people with advanced HIV in South Africa, followed by a research fellowship at the San Antonio Center for Medical Mycology.

He spent 4 years as a transplant ID physician and researcher at the University of Alberta in Canada before being recruited to the Duke Mycology Research Unit in August 2022.


Philip Suffys

Philip Suffys graduated in biology from the State University of Gent, Belgium (1985). He received his PhD degree in molecular biology at the same University (1989).

In 1990, he started working at the Oswaldo Cruz Institute at Fiocruz (Rio de Janeiro, Brazil), which belongs to the Pasteur Network. There, he heads the Laboratory of Molecular Biology Applied to Mycobacteria.

Dr. Suffys has strong expertise in genetics and microbiology with special emphasis on mycobacteria-related issues, including molecular typing, genomics, phylogeny, and drug resistance in tuberculosis, leprosy and mycobacteriosis.

Recently, he has also been active in Legionella infections and syphilis. Between 2015 and 2016, he completed a post-doc at the Institute of Tropical Medicine in Antwerp. He is an author of more than 150 research papers in peer-reviewed journals and his h-index exceeds 30.

Philip Supply

Philip Supply is a Research Director of the National Center for Scientific Research at the Institut Pasteur de Lille, France. 

He dedicates his research to the genomics and evolution of Mycobacterium tuberculosis. Based on the discovery of evolutionarily early branching lineages of tubercle bacilli, his work provided unique insights into the origin and emergence of the pathogen. 

He developed the 24-locus MIRU-VNTR genotyping approach adopted as the worldwide standard for epidemiological tracing and surveillance in the pre-genomic era. 

Together with GenoScreen, he designed and developed the Deeplex®-MycTB kit, representing the most comprehensive test available for culture-free diagnosis of drug resistant tuberculosis based on targeted next generation sequencing. 

Michel Tibayrenc

Michel Tibayrenc has worked on the genetics and evolution of infectious diseases for more than 35 years.

He is a director of research emeritus at the French Institut de Recherche pour le Développement (IRD), founder and editor-in-chief emeritus of Infection, Genetics and Evolution (Elsevier), and founder and principal organizer of the international congresses MEEGID (molecular epidemiology and evolutionary genetics of infectious diseases), supported and managed by Elsevier.

He is the author of more than 200 international papers (H index = 49). He has published 6 scientific books: (1) American trypanosomiasis: Chagas disease. 100 years of discovery (Elsevier; first editor: Jenny Telleria; 2010; reedited 2017); (2) Genetics and evolution of infectious diseases (Elsevier; 2010; reedited 2017; 3rd edition planned 2022); (3) On Human Nature (Elsevier/Academic press; 2016; coeditor: Francisco J. Ayala); (4) What makes us humans (2020; Nova science publishing; coeditor: Francisco J. Ayala).; (5) Spanish edition: Lo que nos hace humanos (SAL TERRAE; coauthor: Francisco J. Ayala); (6) French edition: Notre humaine nature (éditions rue de Seine, Paris; in press; coauthor: Francisco J. Ayala).

Together with his collaborator – Jenny Telleria, he is the founder and scientific adviser of the Bolivian Society of Human Genetics (2012).

Violeta Valcheva

Violeta Valcheva is the Head of Laboratory of molecular biology of mycobacteria in the Department of Infectious Microbiology, at The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria. She is an Associate Professor at the The Stephan Angeloff Institute of Microbiology (SAIM), Bulgarian Academy of Sciences, Sofia, Bulgaria.

In 2009 she received her PhD and conducted the first comprehensive study of molecular characterisation and drug resistance of Mycobacterium tuberculosis strains in Bulgaria. The main research topics of her work are the molecular epidemiology, phylogeny and evolution of mycobacteria, bioinformatics, bacterial pathogenesis and virulence; new synthesized compounds with chemical and natural products, drug development, pharmacokinetics, anti-TB chemotherapy.

She gained experience and high qualifications at various international institutions (in France, Russia, China, Japan) with visible results (projects, publications, establishing new innovations and collaborations). She is responsible for public relations at SAIM, and for SAIM’s scientific relation in the International Pasteur Network. She was a secretary of the Microbiology department in the Bulgarian Union of Scientists in the period of 2009-2013.

Jose Vazquez-Boland

José Vázquez-Boland is a Professor at the University of Edinburgh’s Medical School where he holds the chair of infectious diseases. He has a veterinary degree from Complutense University of Madrid (1985), a diploma in public health (1986), and spent time in clinical practice and as public health officer before earning his PhD degree (1990). After postdoctoral studies at the Institut Pasteur (1990-1991), back in Spain he established a research group in microbial pathogenesis. A University Professor since 1993, in 2002 he took up a chair of molecular microbiology at the University of Bristol before moving to Scotland in 2007. His research interests lie primarily in the virulence, adaptive mechanisms and genomics of facultative pathogens with a focus on Listeria and Rhodococcus equi. He received the Spanish Society for Microbiology “Jaime Ferran” biennial award, the EU Descartes Prize for Transnational Cooperative Research, and is an elected Fellow of the American Academy of Microbiology. 

Miguel Viveiros

Migule Viveiros is a professor in Biomedical Sciences – Medical Microbiology and Global Health, Vice-Director of the Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon, Portugal. Devoted to the early diagnosis and molecular epidemiology of TB and new therapeutics for MDRTB and XDRTB.

He is a specialist in the diagnosis of antibiotic resistance in bacteria by phenotypic and genotypic assays; executive committee member of the Study Group for Mycobacterial Infections of ESCMID; Scientific Coordinator of ‘Ciência LP’ – Center for Advanced Training in Fundamental Sciences for Scientists from Portuguese-speaking Countries (UNESCO Category 2 Center) and Vice-President of the Portuguese Society for Microbiology.

He’s an author/co-author of over 200 scientific papers in peer reviewed journals and books in the field of mycobacteriology, resistance to antibiotics and microbial genetics.

Michal Wandel

Michal Wandel is an EMBO Installation Grantee and a leader of the Laboratory of Intracellular Immunity (at the IBB PAS, Warsaw, Poland), who employs combination of molecular biology, cell biology, biochemistry and microbiology to investigate intracellular anti-microbial defense mechanisms of innate immunity.

Michal obtained his PhD at the University of Cambridge and then significantly contributed to the understanding of host-pathogen interactions during his postdoctoral research at the MRC Laboratory of Molecular Biology in Cambridge, where he investigated how interferon-enhanced immunity protects the host cells against bacterial invasion and discovered the GBP-CASP4 signaling platform.

Daniel Wibberg

Dr. Daniel Wibberg is a bioinformatician, data manager and trainer with more than ten years of experience working with all kind of sequencing data. Daniel holds a BSc in Bioinformatics & Genome Research and a Master’s Degree in Genome based Systems Biology both from Bielefeld University. In his PhD thesis, he analyzed the genome and transcriptome of the pathogenic fungus Rhizoctonia solani AG1-IB.

Daniel specializes in genomics, transcriptomics and metagenomics and was involved in more than 250 different projects. Since 2015, he is working as training coordinator and trainer in the German Network for Bioinformatics Infrastructure (de.NBI) representing the German ELIXIR node. From 2022, the Forschungszentrum Jülich GmbH as a member of the Helmholtz Association of German Research Centers has been entrusted with the consolidation of the de.NBI / ELIXIR Germany. Therefore, Daniel is member of ELIXIR Germany administration office of Institute of Bio- and Geosciences (IBG) 5 “Computational metagenomics” at FZ Jülich.


Judith Armitage

Judith Armitage FRS is Professor of Bacterial Biochemistry at University of Oxford. Her research has centred on bacterial responses to changes in their local environment, specifically how they control swimming to move to favourable environments, combining molecular genetics and biochemistry with biophysics, single molecule live cell imaging and modelling. She is a Fellow of The Royal Society, American Society of Microbiology, European Society of Microbiology and a member of EMBO. She was President of the Microbiology Society from 2019-2022. Her independent career was enabled by a Lister Institute Fellowship and she has been a member of their Governing Body since 2015.

In addition to being a Fellow of the Lister Institute, Judith is a Fellow of The Royal Society, American Society of Microbiology, European Society of Microbiology and a member of EMBO. She was President of the Microbiology Society from 2019-2022.

Hilary Lappin-Scott

Hilary-Lappin Scott is a Professor of Microbiology and has had an extensive career as a research scientist at Exeter University for 20 years, prior to moving into senior University leadership roles. She’s been appointed to Pro-Vice-Chancellor for research and innovation at Bangor University before moving to Swansea University in 2010. Hilary is the third female President of FEMS, and the first from the UK and Ireland. She is a renowned microbiologist who has spent majority of her career researching microbial biofilm communities. Hilary has also been an active ambassador for science and microbiology, and is an avid supporter of advancing science for people of all identities and backgrounds. Hilary is a former President of the Microbiology Society, one of our Member Societies and is a previous President of ISME.

Agata Budkowska

After completing an MSc in Biological Sciences at the University of Warsaw followed by a PhD, she was in charge of the Immunochem­istry Laboratory at the National Institute of Public Health in Warsaw. She then moved to the USA to work at the National Institutes of Health (NIH) in Bethesda with an International Fogarty Centre Fellowship. She joined the Pas­teur Institute in Paris in 1985, where she for 30 years headed research on Hepatitis B (HBV) and Hepatitis C (HCV) viruses.

She was first to elucidate the structure and properties of HBV nucleocapsids, the role of the HBV envelope Pre-S proteins and corresponding antibodies in HBV infection and for vac­cination. Next, she investigated HBV cell entry mechanisms and the role of hepatic receptors in the initiation of the HBV infection.

She discovered non-enveloped HCV nucleocapsids circulating in the blood of infected patients, and described their structure and properties. She initiated studies and demonstrated the essential role of lipoproteins in the formation of HCV virions, in the HCV cell entry via interaction with hepatic lipoprotein receptors and their role in the virus escape mechanisms from the host immune response.

Following her successful career as a Chief of Laboratory at the Pasteur Institute in Paris, she continued her involvement with the Institute as a Scientific Advisor for the Department of International Affairs.

She was made Professor of Medical Sciences by the President of Poland in 2014.

Waleria Hryniewicz

Waleria Hryniewicz recieved her medical degree from the Warsaw Medical University. She was the recipient of the Wellcome Trust grant for research on the biological properties of L forms of Streptococcus pyogenes, which was also the topic of her PhD thesis at the Warsaw Medical University. She held the position of the head of Staphylococcal and Streptococcal Laboratory focused on purification and activities of toxins. She was a post doctorate fellow at the University of Minnesota, working on the biological properties of streptolysin S, and after return to Poland, she was appointed as a full professor and the scientific director of the National Institute of Hygiene. Finally, she moved to Sera and Vaccine Central Laboratory, now a part of the National Medicine Institute, where, as the managing director, she initiated research on molecular epidemiology of invasive bacterial infections, in particular on pneumococci and meningococci and the epidemiology and mechanism of antibiotic resistance of major human pathogens with special emphasis on Gram-positive cocci. She was the chair of the Microbiology Committee of the Polish Academy of Sciences and the President of the Polish Society of Microbiologist.She also served as the national consultant to the Ministry of Health for clinical microbiology. She published over 350 papers mostly in international peer review journals. She is an ESCMID fellow and among the world’s top 2% of the most cited scientists, according to the University of Standford list.

Grzegorz Wegrzyn

Grzegorz Wegrzyn obtained his PhD degree in 1991 at University of Gdansk (Poland). Then, he was a research fellow at University of Nottingham (UK), and a post-doctoral researcher at University of California at San Diego (USA). Since 1996 he is a Professor and Head of Department of Molecular Biology at the University of Gdansk (Poland). His research is focused on regulation of gene expression and DNA replication, control of development of bacteriophages, and mechanisms and new treatment methods of human genetic and neurodegenerative diseases. He supervised 54 PhD theses, led over 30 research projects, and published over 400 scientific articles. He is an editor in several scientific journals.